Active substance
Results for the substance letrozole
20 results
About this active substance
Letrozole is an aromatase inhibitor used for the treatment of hormone-dependent breast cancer in postmenopausal women. It works by reducing estrogen levels, thereby inhibiting the growth of hormone-sensitive tumors.
The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include hot flashes, fatigue, joint pain, or osteoporosis. In rare cases, allergic reactions or liver disorders may occur.
Letrozole is not recommended for pregnant or breastfeeding women or patients with hypersensitivity to this medication.
The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include hot flashes, fatigue, joint pain, or osteoporosis. In rare cases, allergic reactions or liver disorders may occur.
Letrozole is not recommended for pregnant or breastfeeding women or patients with hypersensitivity to this medication.
-
-
ZEQUIPRA 2.5mg film-coated tablets NEOLA PHARMA
-
LETROZOL ALVOGEN 2.5mg film-coated tablets
-
LETROZOL LABORMED 2.5mg film-coated tablets
-
ETRUZIL 2.5mg film-coated tablets EGIS
-
ELOZORA 2.5mg film-coated tablets TEVA
-
TROZEL 2.5mg film-coated tablets GLENMARK
-
LEZRA 2.5mg film-coated tablets TEVA
-
LORTANDA 2.5mg film-coated tablets KRKA
-
FEMARA 2.5mg film-coated tablets NOVARTIS ORIGINAL MEDICINE
-
LETROZOL ATB 2.5mg film-coated tablets ANTIBIOTICE
-
LETROZOL TERAPIA 2.5mg film-coated tablets
-
LETROZOL KABI 2.5mg film-coated tablets FRESENIUS
-
LETROZOL STADA 2.5mg film-coated tablets
-
LETROZOL TEVA 2.5mg film-coated tablets
-
LETROZOL SANOFI-AVENTIS 2.5mg film-coated tablets
-
LETROZOLE MEDICO UNO 2.5mg film-coated tablets
-
LETROZOL POLIPHARMA 2.5mg film-coated tablets
-
ZOTROL 2.5mg film-coated tablets SANDOZ
-
LETROZOL MYLAN 2.5mg film-coated tablets GENERICS